JOEL ACKERMAN
Profile
First Name
: JOEL
Middle Name
:
Last Name
: ACKERMAN
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
DOUGLAS D. BURKETT, PH.D., ARTHUR EPKER, III, GARY GEMIGNANI, JAMES M. MARTELL, JAMES MCGORRY, DANIEL MENDELSON, DAVID MILLER, RONNIE MORRIS, RONNIE MORRIS, M.D., ABBA D. POLIAKOFF, ABBA DAVID POLIAKOFF, MARK R. SCHONAU, DAVID SIDRANKSKY, DAVID SIDRANSKY, DAVID SIDRANSKY, M.D., ANA STANCIC, ANA I. STANCIC, SCOTT TOBIN
EXECUTIVE OFFICER, DIRECTOR
DOUGLAS D. BURKETT, PH.D., ARTHUR EPKER, III, GARY GEMIGNANI, JAMES M. MARTELL, JAMES MCGORRY, DANIEL MENDELSON, DAVID MILLER, RONNIE MORRIS, RONNIE MORRIS, M.D., ABBA D. POLIAKOFF, ABBA DAVID POLIAKOFF, MARK R. SCHONAU, DAVID SIDRANKSKY, DAVID SIDRANSKY, DAVID SIDRANSKY, M.D., ANA STANCIC, ANA I. STANCIC, SCOTT TOBIN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$5,000,001 - $25,000,000
Equity
2015-03-13
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$5,000,001 - $25,000,000
Debt
2014-12-01
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$5,000,001 - $25,000,000
Equity
2013-01-28
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2012-02-08
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2011-04-04
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2011-03-25
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
2010-10-25
